Ofloxacin Oral Suspension (50 mg / 5 ml)
Healthy Inc is a specialized global supplier and exporter of advanced anti-infectives, pediatric medicine, and critical-care therapeutics. We provide ultra-high-purity, kinetically stabilized Ofloxacin Suspension, manufactured in WHO–GMP certified, high-precision liquid manufacturing facilities. This “Second-Generation Fluoroquinolone” is a massive-volume strategic export to retail pharmacies, pediatric hospitals, and government health ministries, serving as the globally preferred intervention for severe bacterial infections that do not respond to traditional penicillins or cephalosporins.
Product Overview
This formulation operates as a “Bactericidal DNA Disruptor.” It physically enters the bacterial cell and shuts down its ability to repair or replicate its genetic code.
Mechanism 1 (DNA Gyrase Inhibition): Ofloxacin physically binds to DNA Gyrase (Topoisomerase II) in Gram-negative bacteria. This stops the “unwinding” of DNA, physically preventing replication.
Mechanism 2 (Topoisomerase IV Inhibition): In Gram-positive bacteria, it physically inhibits Topoisomerase IV, the enzyme required to separate newly replicated DNA strands.
Mechanism 3 (Broad-Spectrum Efficacy): It physically eliminates a wide range of pathogens including E. coli, Salmonella typhi, Shigella, and Haemophilus influenzae.
Product Composition & Strength
We supply this product as a Sterile, Homogeneous, Micronized Suspension, optimized for high stability and pediatric compliance.
| Active Ingredient | Strength (per 5ml) | Primary Clinical Function |
| Ofloxacin IP/BP/USP | 50 mg | The Antibacterial: Eradicates Gram-negative/positive pathogens. |
| Excipients | Xanthan Gum / Sorbitol | The Matrix: Ensures uniform drug dispersion. |
| Flavoring | Orange / Mixed Fruit / Mango | The Palatable Base: Essential for child compliance. |
Technical & Logistics Specifications
HS Code: 3004.20.19 (Medicaments containing other antibiotics)
CAS Number: 82419-36-1 (Ofloxacin)
Dosage Form: Oral Liquid (Suspension)
Packaging: 30ml / 60ml Amber PET or Glass Bottles with child-resistant caps. Our specialized packaging ensures 36-month stability in Zone IVb tropical climates.
Manufacturing Authority & Compliance
Micronized Homogenization: Ofloxacin is physically insoluble in water. Our manufacturing process utilizes High-Shear Homogenization to ensure the drug is perfectly micronized, preventing “caking” and ensuring an exact 50mg dose in every spoon.
Aseptic Liquid Filling: We utilize Automated Liquid Filling Lines with 100% microbial testing to ensure total safety for children and infants.
Photostability Protection: Ofloxacin is physically sensitive to light. We utilize USP Type-III Amber Bottles and light-blocking secondary packaging to ensure 100% chemical integrity.
Primary Indications
Pediatrics: Treatment of Typhoid Fever (Enteric Fever) and severe infectious diarrhea.
ENT Medicine: Management of chronic Otitis Media (Ear infection) and Sinusitis.
Urology: Treatment of complicated Urinary Tract Infections (UTIs) in children.
Respiratory: Management of community-acquired pneumonia and bronchitis.
Dosage & Administration
Standard Regimen: Typically 10 mg/kg to 15 mg/kg per day in two divided doses.
Administration: For maximum safety and to reduce potential gastric upset, it should physically be taken 1 hour before or 2 hours after food.
Shake Well: The bottle must be physically shaken before each use to ensure uniform drug distribution.
Safety Warning: For Oral Use Only. Tendon Note: While rare in children, Ofloxacin use should be physically monitored for any joint or tendon pain. Sun Note: Ofloxacin may physically cause Photosensitivity; keep the child out of direct sunlight during treatment. Contraindication: Do not use in patients with a history of hypersensitivity to Quinolones or those with pre-existing tendon disorders.
Global Export & Contract Manufacturing
Healthy Inc is a premier Anti-Infective and Pediatric Pharmaceutical Exporter in India. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) for high-volume Ofloxacin suspensions. Whether you are a National Health Tender in the CIS or a B2B Pharma Marketplace partner in Africa or SE Asia, we ensure secure, WHO-GMP compliant delivery.